A study by Khan et al. suggested that emodin succinyl ester inhibited the proliferation and migration of HCC cells by targeting the interaction between EZH2 and androgen receptor to inhibit progression of HCC [86]. The gene discussed is EZH2; the disease is hepatocellular carcinoma.